We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
Cap. Flow
+$15.7M
Cap. Flow %
10.5%
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.11M
2
CELG
Celgene Corp
CELG
+$1.11M
3
NKE icon
Nike
NKE
+$1.03M
4
PAY
Verifone Systems Inc
PAY
+$959K
5
MON
Monsanto Co
MON
+$894K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.43M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$2.19M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.41M
4
EPD icon
Enterprise Products Partners
EPD
+$1.02M
5
MGA icon
Magna International
MGA
+$933K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.63%
2 Healthcare 14.32%
3 Technology 11.92%
4 Industrials 11.68%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVH icon
526
PVH
PVH
$3.59B
– –
-3,200
Closed -$236K
PZZA icon
527
Papa John's
PZZA
$999M
– –
-4,600
Closed -$257K
RARE icon
528
Ultragenyx Pharmaceutical
RARE
$2.66B
– –
-2,600
Closed -$292K
RF icon
529
Regions Financial
RF
$26.2B
– –
-12,900
Closed -$124K
RGEN icon
530
Repligen
RGEN
$7.76B
– –
-8,400
Closed -$238K
RGLS
531
DELISTED
Regulus Therapeutics
RGLS
– –
-133
Closed -$140K
ROK icon
532
Rockwell Automation
ROK
$51.3B
– –
-2,100
Closed -$215K
SBGI icon
533
Sinclair Inc
SBGI
$965M
– –
-8,900
Closed -$290K
SBRA icon
534
Sabra Healthcare REIT
SBRA
$5.56B
– –
-12,800
Closed -$259K
SIMO icon
535
Silicon Motion
SIMO
$9.8B
– –
-9,800
Closed -$307K
SLG icon
536
SL Green Realty
SLG
$3.81B
– –
-1,963
Closed -$215K
SNCR
537
DELISTED
Synchronoss Technologies
SNCR
– –
-678
Closed -$215K
SO icon
538
Southern Company
SO
$109B
– –
-5,800
Closed -$271K
SOHU
539
Sohu.com
SOHU
$331M
– –
-5,300
Closed -$303K
SSP icon
540
E.W. Scripps
SSP
$269M
– –
-10,100
Closed -$192K
STAG icon
541
STAG Industrial
STAG
$7.74B
– –
-10,100
Closed -$186K
SUPN icon
542
Supernus Pharmaceuticals
SUPN
$2.74B
– –
-15,400
Closed -$207K
SWBI icon
543
Smith & Wesson
SWBI
$645M
– –
-21,076
Closed -$356K
TBI
544
Trueblue
TBI
$232M
– –
-23,200
Closed -$598K
TCBI icon
545
Texas Capital Bancshares
TCBI
$4.29B
– –
-4,400
Closed -$217K
TDS icon
546
Telephone and Data Systems
TDS
$3.83B
– –
-15,500
Closed -$401K
TEL icon
547
TE Connectivity
TEL
$57.6B
– –
-5,700
Closed -$368K
TER icon
548
Teradyne
TER
$58.5B
– –
-15,200
Closed -$314K
TGNA
549
DELISTED
TEGNA Inc
TGNA
– –
-21,406
Closed -$350K
THRM icon
550
Gentherm
THRM
$1.4B
– –
-5,500
Closed -$261K
20 21
22
23 24

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q1 2016 Portfolio in Review

As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.

  • Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
  • Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
  • Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
  • Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
  • Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
  • Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.

Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.